Glaukos Corporation (GKOS)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Glaukos Corporation (GKOS)
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Key Insights
Critical company metrics and information
Share Price
$141.29Market Cap
$7.79 BillionTotal Outstanding Shares
55.14 Million SharesTotal Employees
907Dividend
No dividendIPO Date
June 25, 2015SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.glaukos.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $38.73 Million |
Net Cash Flow | $-10.64 Million |
Net Cash Flow From Investing Activities, Continuing | $23.12 Million |
Net Cash Flow From Investing Activities | $23.12 Million |
Net Cash Flow From Operating Activities, Continuing | $-72.49 Million |
Net Cash Flow From Operating Activities | $-72.49 Million |
Net Cash Flow, Continuing | $-10.64 Million |
Net Cash Flow From Financing Activities | $38.73 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Operating Expenses | $153.19 Million |
Income/Loss From Continuing Operations After Tax | $-149.57 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-149.57 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Cost Of Revenue | $84.28 Million |
Gross Profit | $276.06 Million |
Basic Average Shares | $51.95 Million |
Basic Earnings Per Share | $-2.96 |
Operating Income/Loss | $-132.32 Million |
Net Income/Loss Attributable To Parent | $-149.57 Million |
Income/Loss From Continuing Operations Before Tax | $-148.63 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Costs And Expenses | $508.97 Million |
Selling, General, and Administrative Expenses | $255.20 Million |
Income Tax Expense/Benefit | $946,000.00 |
Operating Expenses | $408.39 Million |
Benefits Costs and Expenses | $508.97 Million |
Nonoperating Income/Loss | $-16.30 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Diluted Average Shares | $51.95 Million |
Diluted Earnings Per Share | $-2.96 |
Net Income/Loss | $-149.57 Million |
Revenues | $360.35 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Other Current Assets | $337.39 Million |
Other Non-current Assets | $161.26 Million |
Current Liabilities | $71.68 Million |
Equity | $668.51 Million |
Liabilities | $258.03 Million |
Fixed Assets | $98.58 Million |
Noncurrent Assets | $529.26 Million |
Equity Attributable To Parent | $668.51 Million |
Liabilities And Equity | $926.54 Million |
Accounts Payable | $11.10 Million |
Noncurrent Liabilities | $186.35 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Intangible Assets | $269.42 Million |
Inventory | $59.90 Million |
Assets | $926.54 Million |
Other Current Liabilities | $60.58 Million |
Current Assets | $397.28 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.